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Ketogenic Diet Therapies in
Children and Adults with Epilepsy
Matthew Charles Lee Phillips
Abstract
Despite a wide array of anti-epileptic drugs and the option of surgery, one-third
of children and adults with epilepsy continue to suffer from drug-resistant seizures.
Many of these patients may benefit from a ketogenic diet, a non-pharmacologic
therapy proven to improve seizure control in epilepsy. Ketogenic diets aim to mimic
the metabolic profile of fasting, and probably improve seizure control through a
variety of mechanisms that collectively stabilize synaptic function. Although many
similarities exist with regards to patient selection, patient preparation, and diet
implementation in children compared to adults, there are also important differ-
ences. The most conspicuous challenge to the more widespread use of ketogenic
diets in children and adults with epilepsy is a lack of access to ketogenic services in
many regions of the world. Moreover, the culinary and social restrictions associated
with conventional ketogenic diets pose a significant barrier to their use in adults.
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1. Introduction
Epilepsy is defined by recurrent, spontaneous seizures arising from
hyperexcitable neurons in the brain. Yet despite a wide array of anti-epileptic drugs
and the option of surgery, approximately one-third of children and adults with
epilepsy continue to experience drug-resistant seizures [1]. Many of these patients
may be candidates for a ketogenic diet, a well-established, non-pharmacologic
therapeutic option proven to improve seizure control in epilepsy [2, 3].
The origins of ketogenic diets derive from the ancient practice of fasting [4],
widely acknowledged as effective in treating epilepsy since the 5th century BC;
indeed, until the 19th century, epilepsy was believed to be a disease of “eating too
much” [5]. Depending on a person’s body fat stores, fasting can be maintained for a
considerable length of time (the record for a single continuous fast is 382 days) [6].
However, since everyone must eventually eat, fasting is not a feasible long-term
solution for seizure control in epilepsy.
In 1921, Wilder addressed this problem by developing a high-fat, low-
carbohydrate diet designed to mimic the metabolic profile of fasting [4]. The high-
fat, low-carbohydrate nature of the diet elevated blood ketones and lowered blood
glucose levels, producing a metabolic profile similar to that of a multi-day fast. Unlike
fasting, Wilder’s diet provided adequate long-term nutrient intake, thus preventing
malnutrition and promoting healthy long-term growth and development. Since the
diet increased hepatic ketogenesis, it became known as a “ketogenic diet.”
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2. Ketogenic diets
In essence, a ketogenic diet is any high-fat, adequate-protein, low-carbohydrate
diet that forces the body to burn fats—not carbohydrates—as the primary energy
source [7, 8]. During this process, the liver converts fats into ketone bodies, or
“ketones” (organic molecules that readily serve as energy substrates for non-hepatic
organs, particularly brain, heart, and skeletal muscle) [9]. The three endogenous
ketones are acetone, acetoacetate, and beta-hydroxybutyrate (BHB) [7]; BHB is the
primary blood ketone. During a sustained ketogenic diet, the blood BHB level is
elevated, and lies within the range of 0.5–8 mmol/L, constituting a state of “physi-
ological ketosis” (in contrast to pathological ketoacidosis, which is associated with a
blood BHB level of 15–20 mmol/L or higher, and a concomitant lowering of blood
pH) [10].
2.1 Mechanisms of ketogenic diets in epilepsy
Ketogenic diets appear to improve seizure control through a variety of mecha-
nisms that collectively stabilize neuron synaptic function (Table 1) [7, 8]. It is not
known whether the key mediators of improved seizure control are the ketones
themselves, or additional metabolic changes induced by the diets [11].
2.1.1 Ketones as key mediators of seizure control
The most conspicuous metabolic change induced by a ketogenic diet is elevated
blood ketone levels [7]. While it is well-documented that ketones enhance neuron
energetics, accumulating evidence suggests they may also play direct and indirect
roles in reducing neuron excitability, exerting direct antiseizure effects, and
decreasing generation of reactive oxygen species and inflammatory mediators
[7, 8, 11]. Thus, there are multiple avenues by which ketones may contribute to
improved seizure control; they are not just “energy molecules” [11].
Ketones enhance intracellular adenosine triphosphate (ATP) levels and bioener-
getic capacity by increasing mitochondrial oxidative phosphorylation [12]. The
oxidation of acetoacetate and BHB feeds acetyl-CoA directly into the Krebs cycle
General mechanism Specific mechanism
Enhanced neuron energetics Enhanced neuron ATP production
Stimulated mitochondrial biogenesis
Reduced neuron excitability Hyperpolarized potassium channels
Altered glutamate to GABA ratio
Increased extracellular adenosine
Direct antiseizure effects Ketone-mediated antiseizure effects
Raised medium-chain fatty acids
Reduced glucose metabolism
Other mechanisms Reduced oxidative stress
Reduced inflammation
ATP = adenosine triphosphate; GABA = γ-aminobutyric acid.
Table 1.
Mechanisms through which ketogenic diets may stabilize synaptic function.
2
Epilepsy - Advances in Diagnosis and Therapy
through anaplerosis (the replenishing of depleted metabolic cycle intermediates)
[7], which increases the turnover of the Krebs cycle, generating additional protons
and electrons that are channeled to the electron transport chain where they may be
used to enhance ATP production [12].
Ketones may also inhibit neuronal excitability. ATP-dependent potassium chan-
nels, which hyperpolarize the cell membrane, are activated by ketones, decreasing
spontaneous cell firing rates [13]. Moreover, acetoacetate concentrations well
within the range produced by a ketogenic diet inhibit vesicle loading of the excit-
atory neurotransmitter glutamate, resulting in reduced glutamate release into the
synapse and enhanced synthesis of the inhibitory neurotransmitter γ-aminobutyric
acid (GABA) [14]. It is thought that the ensuing altered glutamate to GABA ratio
reduces neuron excitability.
Studies dating back to the 1930s also support the direct antiseizure effects of
ketones [15, 16]. In mice, acetone and acetoacetate raise seizure thresholds,
resulting in fewer seizures [15, 16]. Although BHB did not appear to contribute to
antiseizure effects in these earlier studies, more recent studies indicate that BHB
probably does play a direct antiseizure role, and that its effects may have been
previously missed for methodological reasons [11].
Lastly, ketones may influence seizure control by lowering cell oxidative stress
and inflammation [11]. BHB inhibits histone deacetylases (enzymes that remove
acetyl groups from lysine residues on histones, allowing DNA to wrap tightly and
preventing gene expression), resulting in upregulated anti-oxidant genes and
reduced oxidative stress in kidney cells [17]. Moreover, BHB inhibits the assembly
of the immune sensor nucleotide oligomerization domain (NOD)-like receptor
protein 3, a multi-protein complex that controls the release of various inflammatory
mediators [18].
2.1.2 Additional metabolic changes that may mediate seizure control
Emerging evidence suggests that a number of additional metabolic changes
induced by ketogenic diets may also contribute to enhanced neuron energetics,
reduced neuron excitability, and direct antiseizure effects, improving seizure
control [7, 8].
Ketogenic diets can improve seizure control in patients with mitochondrial
disorders [19]. This observation may be partly explained by the action of the
medium-chain fatty acid, decanoic acid, on peroxisomal proliferator-activated
receptor γ, which stimulates neuronal mitochondrial biogenesis [19]. The increased
mitochondrial biomass enhances neuron ATP production capacity and cell energy
reserves.
Ketogenic diets may also alter brain levels of the neurotransmitter adenosine.
The disruption of adenosine signaling induces seizures; this effect is reversible by a
ketogenic diet [20]. This observation suggests that the diet increases extracellular
adenosine levels, activating inhibitory adenosine A1 receptors and reducing neuron
hyperexcitability [7].
Lastly, ketogenic diets may exert direct antiseizure effects by raising medium-
chain fatty acid levels and decreasing glucose metabolism [7, 8]. The medium-chain
fatty acid, decanoic acid, blocks seizure-like activity in animals [21]. Moreover,
since the antiseizure effects of ketogenic diets can be rapidly reversed by glucose
infusions, decreased glucose metabolism is thought to contribute to seizure control.
The mechanism for this effect could be partially explained by the observation that
ketogenic diets induce a reduction in glycolysis, subsequently repressing the
expression of brain-derived neurotrophic factor, a known pro-convulsant [7].
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2.2 Conventional ketogenic diets in epilepsy
To date, four major, “conventional” ketogenic diets are supported by published
evidence in the treatment of children and adults with epilepsy (Table 2) [2, 3]. The
primary difference between each diet lies in the ratio of fat to protein plus carbo-
hydrate, described by weight or by calorie intake.
2.2.1 The classic ketogenic diet (CKD)
Created by Wilder in the 1920s [1], the CKD is the oldest of all ketogenic diet
therapies and in its purest form consists of 80% fat by weight (roughly equivalent to
90% fat by caloric intake), translating to a 4:1 ratio of fat to protein plus carbohy-
drate, although a 3:1 ratio or lower can often be used [2]. In the CKD, the fat source
consists predominantly of long-chain fatty acids, obtained from standard foods.
2.2.2 The medium-chain triglyceride (MCT) diet
In an effort to make the ketogenic diet more palatable, the MCT diet was
introduced in the 1970s [22]. In its original form, the MCT diet is 60% fat by weight
(roughly 75% fat by caloric intake), with fat sourced from MCT oils. Since medium-
chain fatty acids yield more ketones per kilocalorie compared to long-chain fatty
acids, the MCT diet allows for a lower overall fat intake, and a greater intake of
protein and carbohydrate, compared to the CKD. A number of patients are prone to
gastrointestinal side-effects on this diet, so a modified MCT diet was created in the
1980s, consisting of 30% medium-chain fatty acids plus 30% long-chain fatty acids
by weight [23].
2.2.3 The modified Atkins diet (MAD)
In the early 2000s, the MAD was shown to be effective in treating epilepsy [24].
The MAD is approximately 50% fat by weight (65–70% fat by caloric intake),
Ketogenic diet Macronutrient ratio (by weight) Macronutrient ratio (by calorie intake)
CKD Fat 80% Fat 90%
Protein 12% Protein 6%
Carbohydrate 8% Carbohydrate 4%
MCT diet Fat 60% Fat 75%
Protein 16% Protein 10%
Carbohydrate 24% Carbohydrate 15%
MAD Fat 50% Fat 65–70%
Protein 35% Protein 25–30%
Carbohydrate 15% Carbohydrate 5%
LGIT diet Fat 40% Fat 60%
Protein 45% Protein 30%
Carbohydrate 15% Carbohydrate 10%
CKD = classic ketogenic diet; MCT = medium-chain triglyceride; MAD = modified Atkins diet; LGIT = low glycemic
index treatment.
Table 2.
Conventional ketogenic diets supported by published evidence in treating epilepsy.
4
Epilepsy - Advances in Diagnosis and Therapy
translating to a 1:1 ratio of fat to protein plus carbohydrate, although no set ratio is
mandated; it may even approach a 4:1 ratio [2]. The MAD eases up on the protein
and carbohydrate restrictions imposed by the CKD and MCT diet, and does not
require food weighing.
2.2.4 The low glycemic index treatment (LGIT) diet
The LGIT, roughly 40% fat by weight (60% fat by caloric intake), was intro-
duced in the early 2000s as a treatment for epilepsy [25]. The design of the LGIT
was based on the hypothesis that stable glucose levels contribute to the seizure
control conferred by ketogenic diets. The LGIT allows for relatively liberal levels of
protein and carbohydrate intake, emphasizing carbohydrates with glycemic indices
less than 50.
3. Ketogenic diet therapies in children with epilepsy
Unfortunately, many children throughout the world still lack access to a pediat-
ric epilepsy center containing a specialized ketogenic service with both inpatient
and outpatient management options [2]. Such a service should consist of a pediatric
neurologist, nurse, dietitian, and ideally case managers, psychologists, social
workers, and pharmacists [2, 26].
3.1 Selecting the right child for a ketogenic diet
Ketogenic diets in children are strongly indicated in drug-resistant epilepsy, two
disorders of brain metabolism, and several other seizure disorders (Table 3) [2].
There is virtually no age restriction as to when the diet may be commenced; in fact,
infants younger than 2 years may be an ideal age group [27].
3.1.1 Drug-resistant epilepsy in children
In 2010, the International League Against Epilepsy (ILAE) defined drug-resistant
epilepsy as the failure of adequate trials of two appropriately chosen, tolerated, and
used anti-epileptic drug schedules (whether as monotherapies or in combination) to
achieve sustained seizure freedom [28]. The drugs must have been appropriate for
the seizure type, tolerated at therapeutic doses, and given a reasonable period of time
to work (at least 6 months) [29] before declaring drug resistance.
When drug-resistant epilepsy is declared, further anti-epileptic drug trials or
epilepsy surgery may be helpful [30]. However, even after carefully excluding
confounding factors and optimizing the drug approach, subsequent trials have only
a slight (about 5%) chance of inducing seizure remission [31]. Surgery should
always be considered in children with drug-resistant epilepsy, especially when a
lesion concordant to the epilepsy is detected on imaging [30], but many children are
not surgical candidates due to a generalized or multifocal epilepsy syndrome, or
nonresectable location of ictal onset.
When drug trials and surgery are no longer feasible, a ketogenic diet is indicated
[2]. Numerous studies have demonstrated the efficacy and safety of using ketogenic
diets to treat drug-resistant epilepsy in children, but until the previous decade there
were no randomized controlled trials. Since 2008, four published randomized con-
trolled trials have compared the efficacy of a ketogenic diet with continued medi-
cations or a placebo arm in children with drug-resistant epilepsy [32–35].
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The first randomized controlled trial compared the efficacy of a CKD versus no
diet intervention in 145 children with drug-resistant epilepsy [32]. After 3 months,
28 children (38%) in the CKD group had a greater than 50% seizure reduction
compared to four children (6%) in the control group. One weakness of the study
was its unblinded design, with both patients and assessors aware of the group
allocations.
The following year, a randomized controlled trial was published in 20 children
with drug-resistant Lennox-Gastaut syndrome [33]. All patients were fasted 36 hours
and then randomized to receive either a CKD plus a daily solution containing 60 g
glucose per day or a solution containing saccharin (an artificial sweetener); the aim of
the design was to ensure that both patients and assessors remained blinded to treat-
ment. To the surprise of the investigators, both groups had positive blood BHB levels
after 6 days, indicating that the glucose solution did not suppress physiological
ketosis. Perhaps as a result of this, the study demonstrated only a borderline, non-
statistically significant reduction in seizures in the saccharin arm.
The next randomized controlled trial compared the efficacy of a MAD versus no
diet intervention in 102 children with drug-resistant epilepsy [34]. Surgical candi-
dates were not excluded. After 3 months, 52% of children in the MAD group had a
greater than 50% seizure reduction compared to 11.5% of those in the control group.
A weakness of the study was its unblinded design, with both patients and assessors
aware of the group allocations.
The most recent randomized controlled trial compared the efficacy of a ketogenic
diet (CKD or MCT diet) versus no diet intervention in 57 children and adolescents
with drug-resistant epilepsy [35]. None of the patients were eligible for surgery. After
4 months, 13 children (50%) in the ketogenic diet group had a greater than 50%
seizure reduction compared to 4 children (18.2%) in the control group.
Pooling the results from these randomized controlled trials suggests that
40–50% of children experience a greater than 50% seizure reduction after
3–4 months on a ketogenic diet, compared to 10–15% of children receiving no
General disorder Specific disorder
Drug-resistant epilepsy 2010 ILAE definition
Disorders of brain metabolism GLUT1 DS
PDHD
Specific seizure disorders Angelman syndrome
Complex I mitochondrial disorders
Doose syndrome
Dravet syndrome
FIRES
Formula-fed
Infantile spasms
Ohtahara syndrome
Super-refractory status epilepticus
Tuberous sclerosis complex
ILAE = International League Against Epilepsy; GLUT1 DS = glucose transporter type 1 deficiency syndrome;
PDHD = pyruvate dehydrogenase complex deficiency; FIRES = febrile infection-related epilepsy syndrome.
Table 3.
Epilepsy disorders in children for which a ketogenic diet may be strongly indicated.
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dietary intervention. Given these encouraging results, many epilepsy specialists
advocate that ketogenic diets be used earlier in the management of children with
drug-resistant epilepsy [2].
3.1.2 Disorders of brain metabolism in children
Since ketogenic diets induce a shift away from glycolytic energy production
towards mitochondrial oxidative phosphorylation, they are the treatment of choice
in two childhood disorders of impaired brain glucose metabolism: glucose trans-
porter type 1 deficiency syndrome (GLUT1 DS) and pyruvate dehydrogenase com-
plex deficiency (PDHD) [2]. In both cases, the ketones produced by the diet bypass
the metabolic defects, serving as an alternative energy source for the brain.
GLUT1 DS results from impaired glucose transport across the blood-brain bar-
rier due to mutations in the SLC2A1 gene, which encodes the glucose transporter,
GLUT1 [36]. Clinically, GLUT1 DS is characterized by cognitive impairment, mixed
seizure types, and a complex movement disorder. The vast majority of children
with GLUT1 DS achieve seizure freedom with a CKD, which should be introduced
as early as possible and continued through to adulthood [36]. The CKD may be
difficult to tolerate in older children and adolescents, in which case the MAD is also
effective [2]. In GLUT1 DS, ketogenic diets may also enhance the child’s alertness,
and they frequently improve the movement disorder [36].
In PDHD, pyruvate is unable to be metabolized into acetyl-CoA, resulting in
abnormal mitochondrial metabolism and lactic acidosis [37]. Clinically, PDHD is
characterized by seizures, severe encephalopathy, and—usually—death during
childhood. The CKD is effective and safe in PDHD, and appears to increase longev-
ity and improve mental development [37]. However, severe forms of PDHD may
not be appropriate for the diet if quality of life is not improved [2].
3.1.3 Specific seizure disorders in children
Ketogenic diets should be considered early in the management of children with
seizure disorders that consistently demonstrate a 60–70% improvement in seizure
control, well above the “usual” 40–50% improvement [2]. These disorders include
Angelman syndrome, complex I mitochondrial disorders, Doose syndrome, Dravet
syndrome, febrile infection-related epilepsy syndrome (FIRES), formula-fed
infants or children, infantile spasms, Ohtahara syndrome, super-refractory status
epilepticus, and tuberous sclerosis complex [2].
3.2 Preparing a child (and caregiver) for a ketogenic diet
Once the child is selected for a ketogenic diet, a medical and nutritional evalua-
tion is both strongly advised (Table 4) [2, 26]. In addition to the caregiver (usually
a parent), anyone else who will be helping institute the diet should attend.
3.2.1 Medical evaluation
A medical evaluation should be performed by a pediatric neurologist experi-
enced in managing ketogenic diets in children, and include an assessment of the
child’s epilepsy, comorbidities, psychological and socioeconomic factors, medica-
tions, and investigations [2].
First, the pediatric neurologist must assess the child’s baseline epilepsy state and
any comorbidities that may complicate a ketogenic diet. Seizure symptomatology
and frequency should be documented in sufficient detail so as to later gauge diet
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efficacy on seizure control. Potential complicating comorbidities include gastroin-
testinal issues (such as gastroesophageal reflux and constipation), hypercholester-
olemia, low weight gain, kidney stones, chronic metabolic acidosis, and
cardiomyopathy [2]. Once identified, most comorbidities can be preventatively
managed.
Second, it is critical to identify psychological, socioeconomic, cultural, and
religious factors that may affect the child’s diet [2]. Challenging behavior traits in
the child or caregiver should be addressed early. Since many patients with epilepsy
are of lower socioeconomic status, an appraisal of the family environment, includ-
ing finances, is essential before deciding to proceed; even if deemed adequate, the
caregiver must be made aware of the impact of a ketogenic diet on time and
resources, including separate meal preparation from the rest of the family and
increased costs [26]. It is also necessary to consider the family’s cultural and reli-
gious background, which may result in some recipes being more suitable than
others [2].
Third, the child’s medications should be reviewed. Generally, blood levels of
common anti-epileptic drugs are not significantly altered by a ketogenic diet, there-
fore dose adjustments are not required. However, it may be worth considering dose
reductions in the case of valproate, zonisamide, and topiramate; although these drugs
are generally safe alongside a ketogenic diet, there have been rare instances of hepa-
totoxicity and secondary carnitine deficiency with valproate, as well as chronic met-
abolic acidosis and a slight increase in kidney stones with zonisamide and topiramate
[2]. All medications should be reviewed for carbohydrate content, which may neces-
sitate a switch to lower carbohydrate preparations [26].
Fourth, the child and caregiver should be provided with a means of self-
monitoring the diet, which critically provides feedback as to how effectively the
child is achieving physiological ketosis [2]. Traditionally, this has been done using
urine ketone dipstick testing, but it is now possible to prescribe a blood glucose and
ketone monitor in many countries. The former is less expensive and avoids finger
pricks, but the latter is easier, more specific, and more accurate [38]. Unless there is
a compelling reason to measure urinary ketones, a blood glucose and ketone moni-
tor should be prescribed and the caregiver instructed on its use.
Finally, investigations should be ordered before commencing a ketogenic diet in
a child, primarily to rule out contraindications (a ketogenic diet is absolutely
contraindicated in disorders of fat metabolism, including carnitine deficiency, car-
nitine palmitoyltransferase I and II deficiency, any of the short, medium, or long-
chain acyl dehydrogenase deficiencies, and porphyria) [2]. Basic laboratory
Evaluation Steps
Medical Assess baseline epilepsy state and comorbidities
Identify psycho-socioeconomic, cultural, and religious factors
Review anti-epileptic drugs and medications
Provide blood glucose and ketone monitor; show how to use
Order investigations
Nutritional Assess baseline physical parameters
Select most appropriate conventional ketogenic diet
Provide supplements
Educate caregiver
Table 4.
Preparing a child (and caregiver) for a ketogenic diet.
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investigations include complete blood count, electrolytes, liver and kidney function
tests, fasting lipid profile, calcium, vitamin D, serum acylcarnitine profile, and a
urinalysis [2]. Baseline anti-epileptic drug levels can be measured, although few
concerns for drug-diet interactions exist. A recent EEG and MRI brain should be
obtained to identify potential surgical candidates. Further tests, such as ECG and
renal ultrasound, may be ordered as clinically indicated.
3.2.2 Nutritional evaluation
A nutritional evaluation should be performed by a dietitian experienced in
managing ketogenic diets in children, and include an assessment of baseline physi-
cal parameters, selection of the most suitable ketogenic diet, and education of the
caregiver on what to expect with the diet.
Baseline weight, body-mass index, and height are routinely measured (in
infants, head circumference is also measured) [2]. The child’s recommended calorie
and fluid intake should be calculated, as well as the desired fat to protein to carbo-
hydrate ratio. Food aversions and allergies must be clearly documented.
When selecting a conventional ketogenic diet for a child, the most important factor
to consider is the family environment, rather than perceived diet efficacy [2]. The
CKD is highly effective for seizure control, but restrictive and time-consuming;
depending on the family environment, it may be more feasible to implement the MCT
diet, MAD, or LGIT diet. Regarding diet efficacy, the CKD appears to be superior to
the MAD in infants under 2 years of age, whereas both are equally effective in older
children [27]. For the transition to adolescence, the MAD and LGIT diet are less
restrictive and more appropriate; the LGIT diet may not provide an adequate level of
ketosis to treat GLUT1 DS and PDHD, although it is highly effective in Angelman
syndrome [2, 39]. For infants and children on enteral feeds, ketogenic diets can be
administered in liquid form, which may be more convenient and efficacious [2].
Given the limited fruit, vegetable, and calcium content in conventional keto-
genic diets, supplementation with a carbohydrate-free multivitamin containing
minerals, as well as supplementation with calcium and vitamin D, is considered
mandatory in children [26]. No particular recommendations exist for
supplementing a ketogenic diet with magnesium, selenium, carnitine, laxatives,
probiotics, or exogenous ketones [2, 26].
Caregiver education is essential; the caregiver needs to understand exactly what
is required of them to implement the diet. A classroom-based format, with several
different caregivers present, can be advantageous [26]. The dietitian should dem-
onstrate how to identify sources of fat, protein, and carbohydrate, how to count net
carbohydrate (total carbohydrate minus fiber) for those on a MAD, how to identify
foods with a low glycemic index for those on an LGIT diet, and how to navigate
potential pitfalls [26]. Helpful additional resources should be provided [40, 41] and
any expectations addressed.
3.3 Implementing a ketogenic diet in a child
Once the child and caregiver have been prepared, it is time to implement the diet
(Table 5) [2]. The pediatric ketogenic service should take on a strong supportive
role, aiding the caregiver as much as possible in troubleshooting problems.
3.3.1 Diet initiation
Currently, it is recommended that the CKD be initiated with the child in hospital
[2]. The advantages of an inpatient admission include the ability to closely observe
9
Ketogenic Diet Therapies in Children and Adults with Epilepsy
DOI: http://dx.doi.org/10.5772/intechopen.83711
the child, medically intervene if necessary, and provide more time to educate the
caregiver on how to maintain the diet upon returning home.
Traditionally, a 12–24 hours fast has been used to commence the diet in an
inpatient setting [2]. Fasting may lead to a quicker onset of seizure reduction, which
may be useful in refractory status epilepticus [2]. However, induction fasts do not
improve ketosis or seizure control at 3 months, and fasted children experience
weight loss, hypoglycemia, and acidosis more frequently, which may increase the
length of hospital stay [42]. Thus, although an induction fast should be considered,
most pediatric ketogenic services no longer routinely fast children, and none rec-
ommend fasting infants under 2 years of age [2].
Regardless of whether an induction fast is utilized, several approaches may be
used to introduce the CKD in hospital [2]. One approach involves starting the diet at
one-third or one-half of the final calorie level, increasing the calories by one-third or
one-half over several days until full calorie intake is achieved, keeping the fat to
protein to carbohydrate ratio constant. Another approach is to start with full calorie
intake, but increase the ratio of fat to protein plus carbohydrate daily, from 1:1 to 2:1
to 3:1 to 4:1, allowing the child to gradually adapt to the increasing fat intake. Yet
another approach is to simply commence the CKD at full calories and a 4:1 ratio on
the first day, which does not appear to prolong hospital stay, increase adverse
effects, or decrease diet efficacy at 3 months.
In older children, the CKD may be initiated as an outpatient, the advantages of
which include reduced family stress and fewer hospital-associated costs [2]. Most
pediatric ketogenic services also routinely initiate the less-restrictive MAD and
LGIT diet in the outpatient setting. If a graded introduction is required at home,
clear instructions must be given to the caregiver on how to do so.
3.3.2 Diet maintenance
Once initiated, ketogenic diets tend to work rapidly and effectively, with 75% of
children responding within 14 days [43]. Complete seizure freedom often occurs
within several months of initiation, although it may take up to 18 months [44]. The
caregiver should monitor the child’s ketone levels (ideally, the blood BHB level)
daily for the first several weeks, then two or three times a week once readings
consistently show the child to be in physiological ketosis. Most pediatric ketogenic
services recommend a blood BHB level of 4–6 mmol/L, although this is not based on
clinical evidence [3]. If seizure control or ketone levels are not responding as
Stage Steps
Initiation Decide whether to initiate as inpatient or outpatient
If inpatient, decide on induction fast and diet introduction
If outpatient, provide clear instructions to caregiver
Maintenance Caregiver monitors seizure control and ketone levels
Review at 1, 3, 6, 9, 12 months, and 6-monthly after
Monitor for adverse effects
Cessation Identify when diet should be ceased (if ever)
If to be ceased, consider switching to another ketogenic diet
If to be ceased, decide on rate of diet cessation
Table 5.
Implementing a ketogenic diet in a child with epilepsy.
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expected, a 3-day food diary may be useful to discover potential oversights in diet
implementation.
The pediatric neurologist and dietitian should be in frequent phone or email
contact with the caregiver during the initial weeks of the diet, with additional
follow-up visits occurring at 1, 3, 6, 9, and 12 months, and every 6 months thereaf-
ter [2]. The pediatric neurologist should document the child’s seizure response, and
regardless of any improvement, resist altering their anti-epileptic drugs unless
necessary; alterations may make it difficult to gauge diet efficacy on seizure control.
Recommended follow-up tests include complete blood count, electrolytes, liver and
kidney function tests, fasting lipid profile, calcium, and vitamin D [2]. Since keto-
genic diets and anti-epileptic drugs may predispose a child to osteopenia, some
pediatric ketogenic services perform a bone density scan after 2 years on the diet
[2]. The dietitian should monitor the child’s physical parameters and nutritional
intake at every visit. Ketogenic diets have a diuretic effect and fluid content in the
food may be lessened, therefore fluid hydration must be monitored, and increased if
necessary [26].
Both the caregiver and the pediatric ketogenic service must monitor the child for
adverse effects. Gastrointestinal symptoms such as nausea, vomiting, abdominal pain,
and constipation appear in up to 50% of children on the CKD, but are easily remedied
by increasing fluid, salt, and fiber intake [2]. Hyperlipidemia is common, with raised
triglyceride and low-density lipoprotein (LDL) levels seen in up to 60% of children on
the CKD, but the increase is usually transient and normalizes within 1 year; if desired,
the LDL can be lowered by altering the types of fats ingested (for example, by
increasing olive oil and decreasing saturated fats) [2]. Moreover, ketogenic diets may
slightly inhibit a child’s growth; adjustments in calorie intake may compensate. Kid-
ney stones may occur in 3–7% of children on the CKD, but can be prevented with oral
citrates [2]. Ultimately, such common adverse effects are rarely sufficient reasons to
discontinue the CKD, but rarer adverse effects such as cardiomyopathy, prolonged
QT interval, and pancreatitis may provide sufficient reason to do so.
3.3.3 Diet cessation
Upon ceasing a ketogenic diet, the long-term benefits on seizure control often
outlast the diet itself. In children who become seizure-free on a ketogenic diet, 80%
will remain so after diet cessation [45], an effect that can persist for many years.
The child’s ketogenic diet should be maintained for at least 3 months before
passing judgment on its efficacy in seizure control [2]. The exception to this rule is
if the seizures worsen for longer than 1–2 weeks after commencing the diet, or if a
serious adverse effect occurs—in either case, it may be wise to discontinue the diet
sooner.
If a child experiences the “usual” greater than 50% seizure reduction, the keto-
genic diet is usually discontinued after 2 years [2]. In new-onset infantile spasms, the
diet can be ceased at 6 months [46]. In drug-resistant epilepsy in which seizure
control is virtually complete (over 90% seizure reduction) and GLUT1 DS, the diet
can be carried into adulthood [2]. Older children may start to see their diet as overly
restrictive; if it effectively controls the seizures, it may be switched over to another
type of ketogenic diet (for example, from a CKD or MCT diet to a MAD or LGIT diet).
A child’s ketogenic diet should be ceased gradually (over several months) [2]. In
the case of the CKD, the ratio can be reduced by decreasing the ratio of fat to
protein plus carbohydrate monthly, from 4:1 to 3:1 to 2:1 to 1:1, allowing the child to
gradually adapt to the decreasing fat intake, followed by the reintroduction of
regular foods. However, it is usually still possible to cease the diet more rapidly
(over several weeks) without negative consequences, although some children may
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experience a higher risk of increased seizures during the tapering-down period. If
medically necessary, ketogenic diets can be stopped abruptly; this is best done in
hospital.
4. Ketogenic diet therapies in adults with epilepsy
Few epilepsy centers in the world offer a dedicated adult ketogenic service [3].
Such a service should consist of a neurologist, nurse, dietitian, and ideally a psy-
chologist and social worker [3, 47].
4.1 Selecting the right adult for a ketogenic diet
Ketogenic diets in adults are indicated in drug-resistant epilepsy and certain
seizure disorders (Table 6); they may be used in adults of all ages [47].
4.1.1 Drug-resistant epilepsy in adults
In 2010, the ILAE defined drug-resistant epilepsy as the failure of adequate trials
of two appropriately chosen, tolerated, and used anti-epileptic drug schedules
(whether as monotherapies or in combination) to achieve sustained seizure free-
dom [28]. Since adults may suffer from drug-resistant epilepsy for decades, many
adult patients have already failed multiple trials of anti-epileptic drugs over their
lifetime.
Further anti-epileptic drug trials and epilepsy surgery may be feasible options in
adults with drug-resistant epilepsy [30]. However, subsequent drug trials confer
only a slight (about 5%) chance of inducing seizure remission [31]. Surgery should
always be considered, but some eligible adults may not be ready to pursue surgery
[48], and many others will not be eligible due to a generalized or multifocal epilepsy
syndrome, or nonresectable lesion of ictal onset.
When drug trials and surgery are not feasible, a ketogenic diet may be indicated
[48]. Many single-arm studies have demonstrated the efficacy and safety of ketogenic
diets in treating drug-resistant epilepsy in adults, but to date there are no randomized
controlled trials of a ketogenic diet in adults with drug-resistant epilepsy.
Surprisingly, a 1930 study remains the largest retrospective case series to exam-
ine a ketogenic diet in adults with epilepsy [49]. In this study, 100 adolescents and
adults with epilepsy were treated with a CKD. After 1–46 months, 56% of patients
had a greater than 50% seizure reduction.
General disorder Specific disorder
Drug-resistant epilepsy 2010 ILAE definition
Disorders of brain metabolism GLUT1 DS
PDHD
Specific seizure disorders JME
Lennox-Gastaut syndrome
Rett syndrome
ILAE = International League Against Epilepsy; GLUT1 DS = GLUT1 deficiency syndrome; PDHD = pyruvate
dehydrogenase complex deficiency; JME = juvenile myoclonic epilepsy.
Table 6.
Epilepsy disorders in adults for which a ketogenic diet may be indicated; this list is not comprehensive.
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In 2014, a review of all subsequently published ketogenic diet studies in adults
with drug-resistant epilepsy was published [50]. Five studies examined the use of a
CKD to treat a combined total of 47 adults with drug-resistant epilepsy. After
3–26 months, 15 patients (32%) had a greater than 50% seizure reduction, with 24
patients (51%) stopping the diet before study completion. Another five studies
examined the use of a MAD to treat a combined total of 85 adults with drug-
resistant epilepsy. After 3–12 months, 24 patients (28%) had a greater than 50%
seizure reduction, with 36 patients (42%) stopping the diet before completion. For
both diets, most patients withdrew due to culinary and social restrictions.
In 2016, the largest observational study of a ketogenic diet in adults with drug-
resistant epilepsy was published, in which 106 patients were treated with a MAD
[48]. After 3 months, 38 patients (36%) had a greater than 50% seizure reduction,
with 47 patients (44%) not completing the study, largely due to diet restrictiveness.
Pooling the results from these single-arm studies suggests that 30–40% of adults
with drug-resistant epilepsy experience a greater than 50% seizure reduction after 3
or more months on a ketogenic diet. While these results are encouraging, they
emanate from single-arm studies; moreover, 40–50% of adults stopped their diet
before study completion. Clearly, randomized controlled trials involving less
restrictive ketogenic diets are needed in adults with drug-resistant epilepsy.
4.1.2 Specific seizure disorders in adults
Ketogenic diets remain standard treatments for disorders of impaired brain
glucose metabolism in adults [47]. In GLUT1 DS, ketogenic diets have been shown
to confer seizure freedom in up to 90% of patients, including adults [47]. The
prognosis in more severe forms of PDHD may be poor, but less severely affected
individuals may benefit from a ketogenic diet as they transition to adulthood.
In addition to GLUT1 DS and PDHD, ketogenic diet therapy may be warranted
in several seizure disorders often seen in adults, including juvenile myoclonic epi-
lepsy (JME), Lennox-Gastaut syndrome, and Rett syndrome [48]. JME is particu-
larly common, representing 5–10% of all epilepsy cases, and typically manifests in
adolescence or early adulthood with a combination of myoclonic jerks or seizures,
absence seizures, and generalized tonic-clonic seizures. In two separate case series,
60–70% of adolescents and adults with JME experienced a 50% seizure reduction
after 3 months of MAD therapy [51, 52].
4.2 Preparing an adult (and partner) for a ketogenic diet
Once the adult has been selected for the diet, a medical and nutritional evalua-
tion is advised (Table 7) [3, 47]. If possible, a cohabiting partner (spouse or family
member) should accompany the adult to the evaluations, and ideally participate in
the diet alongside them.
4.2.1 Medical evaluation
A brief medical evaluation should be performed by a neurologist with experi-
ence managing ketogenic diets in adults, and should include a history of the epi-
lepsy, comorbidities, psychological and socioeconomic factors, level of commitment
to the diet, medications, and investigations [47].
First, the neurologist must ascertain the adult’s baseline epilepsy state and any
comorbidities that may complicate their ketogenic diet. The symptomatology and
frequency of the various types of seizures should be documented in sufficient detail
so as to later gauge diet efficacy on seizure control. Potentially complicating
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comorbidities include hypercholesterolemia, underweight body-mass index, kidney
stones, osteopenia or osteoporosis, gastrointestinal issues (such as gastroesophageal
reflux and constipation), cardiomyopathy, and diabetes [3]. Adults with
type 1 diabetes can safely pursue a ketogenic diet, but must be closely monitored as
their insulin requirements often decline, putting them at risk of hypoglycemia if
they do not adjust their insulin doses accordingly [53]. Adults with type 2 diabetes
may also start a ketogenic diet [3]; in fact, such adults may be ideal candidates.
Second, it is critical to identify psychological, socioeconomic, cultural, and reli-
gious factors with the potential to disrupt the adult’s ketogenic diet [3]. Diet adher-
ence in adults may be endangered by any number of factors, including personality
traits, alcohol habits, income, cultural influences, and religious preferences; each must
be realistically appraised before the adult and ketogenic service commit to the diet.
Third, the adult’s level of commitment to ketogenic diet therapy must be eluci-
dated. Diet modification often involves a major change in lifestyle, therefore any-
thing less than a full commitment is likely to fail. If the adult holds any reservations
about commencing the diet, these should be explored; if unsolvable, the adult may
not yet be ready for the diet. The neurologist should counsel the adult on how to
deal with inevitable “mixed messages” regarding the purported negative aspects of
high-fat diets from friends, family, and even other medical professionals. Lastly, it
can be helpful to emphasize the additional positive aspects of a ketogenic diet, such
as beneficial effects on cognition, energy, and mood [47].
Fourth, the adult’s medications should be reviewed. In general, anti-epileptic
drug blood levels are not altered by a ketogenic diet, therefore dose adjustments are
not usually required. However, for the same reasons as in children, exceptions
might be made in the case of valproate, zonisamide, or topiramate [2]. All medica-
tions should be reviewed for carbohydrate content, which may necessitate a switch
to lower carbohydrate preparations [47].
Fifth, the adult should be provided with a means of self-monitoring their diet,
which critically provides feedback as to how effectively they are achieving physio-
logical ketosis. In adults, it is best to prescribe a blood glucose and ketone monitor
given that this method is easier, more specific, and more accurate than urine
dipstick testing [38]. The adult should be shown how to use the monitor.
Evaluation Steps
Medical Assess baseline epilepsy state and comorbidities
Identify psycho-socioeconomic, cultural, and religious factors
Elucidate level of commitment
Review anti-epileptic drugs and medications
Provide blood glucose and ketone monitor; show how to use
Order investigations
Nutritional Assess baseline physical parameters
Select most appropriate conventional ketogenic diet
If none appropriate, offer a non-conventional ketogenic diet
Provide list of foods for social settings
Provide supplements
Educate patient
Table 7.
Preparing an adult (and partner) for a ketogenic diet.
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Finally, investigations should be ordered to rule out contraindications to a keto-
genic diet (as a rule, it is not necessary to screen for disorders of fat metabolism in
adults, unless the history suggests otherwise) [47]. Laboratory investigations
include complete blood count, electrolytes, liver and kidney function tests, fasting
lipid profile, calcium, vitamin D, and a urinalysis [3]. Given that the effects of a
ketogenic diet on pregnancy are not known [3], pregnancy testing may be indicated
in women of childbearing age. Baseline anti-epileptic drug levels can be measured,
although few concerns for drug-diet interactions exist. A recent EEG and MRI brain
should be obtained to identify potential surgical candidates. Given that ketogenic
diets and anti-epileptic drugs may predispose adults to osteopenia, a baseline bone
density scan may be wise. Further tests, such as ECG and renal ultrasound, are
ordered as clinically indicated.
4.2.2 Nutritional evaluation
A nutritional evaluation should be performed by a dietitian experienced in
managing ketogenic diets in adults, and ought to include an assessment of baseline
physical status, a decision as to which is the most appropriate ketogenic diet option
for that adult, and education about their chosen ketogenic diet.
Baseline weight and body-mass index should be measured and recommended
calorie and fluid intake calculated, including the desired ratio of fat to protein to
carbohydrate [48]. Food aversions and allergies must be clearly documented.
When selecting which conventional ketogenic diet to use, the most important
factors to consider in adults are culinary and social restrictions [48, 50]. Since the
CKD is the most restrictive of the four, it is rarely a viable long-term option in
adults (unless given as a formula). The MCT diet is slightly less restrictive, but still
not viable in most adults due to the copious quantities of MCT oil and resulting
gastrointestinal side-effects. The MAD and LGIT are less restrictive conventional
options in adults, but both are still associated with considerable dropout rates [54].
Thus, although conventional ketogenic diets should be offered, the adult may not be
motivated to pursue any of them; this will negatively impact diet implementation.
If conventional ketogenic diets do not appeal to the adult, a fifth option, that of a
non-conventional ketogenic diet, can be considered. Such a diet might consist of
dietitian-verified recipes obtained from trusted ketogenic diet books and websites, a
major advantage of which is that it can be specifically tailored towards the adult’s
food preferences, reducing the perception that their diet is restrictive. It is now
possible to prepare a variety of ketogenic diets, including vegetarian and culturally-
tailored ketogenic diets (theoretically, as long as a ketogenic diet sustains physio-
logical ketosis, it is “ketogenic”). Given that each conventional ketogenic diet is
decades old (nearly a century old in the case of the CKD), a newer, less restrictive,
patient-tailored ketogenic diet is appealing to many adults, although it must be
emphasized that evidence for such a diet in epilepsy may be lacking.
Since many adults with epilepsy are of lower socioeconomic status, the dietitian
must strive to minimize any socioeconomic impediments that may disrupt their
ketogenic diet. Social activities are to be encouraged, but they can also jeopardize
the diet; it is extremely helpful if the dietitian provides a list of appropriate food
options relevant to most restaurants and social gatherings that will inform the adult
as to what they can and cannot eat, so as not to disrupt the diet. For meals made at
home, the dietitian should recommend foods that are both within the adult’s budget
range as well as readily available at their local food markets.
Given the limited fruit, vegetable, and calcium content in many ketogenic diets,
adults should be commenced on a carbohydrate-free multivitamin [3, 47]. Some
15
Ketogenic Diet Therapies in Children and Adults with Epilepsy
DOI: http://dx.doi.org/10.5772/intechopen.83711
ketogenic services also supplement adults with calcium, vitamin D, and magne-
sium [3, 47].
Lastly, education is essential; the adult needs to understand exactly what is
required of them to implement their diet. A classroom-based format, with multiple
adult patients present, can be advantageous [26]. The dietitian should demonstrate
how to identify sources of fat, protein, and carbohydrate, how to count net carbo-
hydrate (total carbohydrate minus fiber) for those on a MAD or non-conventional
ketogenic diet, how to identify foods with a low glycemic index for those on an
LGIT diet, and how to navigate potential pitfalls [26]. Helpful additional resources
should be provided [55] and any expectations addressed.
4.3 Implementing a ketogenic diet in an adult
Once the adult has been prepared, their chosen diet can be implemented
(Table 8) [47]. The ketogenic service should provide as much support as the adult
needs, but also encourage them to develop a sense of “ownership” over their diet,
thus conferring a feeling of empowerment over their epilepsy.
4.3.1 Diet initiation
In younger and disabled adults, it may be more appropriate to initiate a keto-
genic diet as an inpatient [48]. The advantages of an admission include the ability to
observe the patient and medically intervene if needed, and provide more time to
educate the caregiver on how to maintain the diet upon returning home. In general,
fasting is not employed in adults, although an induction fast might be useful if a
quicker response is required (for example, if the adult is having multiple daily
seizures, an induction fast might lessen the interference of the epilepsy on the
initiation of the diet) [48]. The same graded approach used to introduce the diet in
children may also be used in adults [48].
In most cases, adults with epilepsy can initiate their ketogenic diet as an outpa-
tient, especially if they have selected the MAD, LGIT diet, or a non-conventional
ketogenic diet. In most adults, it is not necessary to employ a graded approach when
initiating a ketogenic diet at home, but if required then clear instructions should be
provided on how to do so.
Stage Steps
Initiation Decide whether to initiate as inpatient or outpatient
If inpatient, decide on induction fast and diet introduction
If outpatient, provide clear instructions to caregiver
Maintenance Adult self-monitors seizure control and ketone levels
Review at 3 and 6 months, and 6-monthly after
Monitor for adverse effects
Document beneficial effects
Cessation Identify when diet should be ceased (if ever)
If to be ceased, consider switching to another ketogenic diet
If to be ceased, decide on rate of diet cessation
If relevant, consider diet cessation and driving
Table 8.
Implementing a ketogenic diet in an adult with epilepsy.
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4.3.2 Diet maintenance
Ketogenic diets often work rapidly, within days [43]. The adult should regularly
monitor their blood BHB level daily for the first several weeks, then two or three
times a week once readings indicate that constant physiological ketosis has been
achieved. There are no firm recommendations regarding optimal blood BHB levels
in adults [3], although aiming for at least 2 mmol/L at all times seems reasonable. If
seizure control or ketone levels are not responding as expected, a 3-day food diary
may be useful to discover potential oversights in diet implementation.
The neurologist or dietitian should be in regular phone or email contact during
the initial weeks of the diet, with multidisciplinary follow-up visits at 3 and
6 months, and every 6 months thereafter [3]. The neurologist should document the
adult’s seizure response to the diet; regardless of any improvement, anti-epileptic
drugs should not be altered unless necessary, as alterations may make it difficult to
gauge diet efficacy on seizure control. Recommended follow-up tests include com-
plete blood count, electrolytes, liver and kidney function tests, fasting lipid profile,
calcium, and vitamin D [47]. If osteopenia is a concern, a bone density scan may be
warranted every 5 years or less [47], and bone protection therapy prescribed as
needed. The dietitian should monitor weight, nutritional intake, and fluid hydration
at every visit, and alter each as required.
Adverse effects may occur in adults on a ketogenic diet, but are generally
transient, and rarely serious enough to necessitate stopping the diet [47]. The two
most common adverse effects in adults are hyperlipidemia and weight loss [48].
Raised LDL levels are seen in least one-quarter of adults with epilepsy [48]. How-
ever, triglyceride levels often decline, and HDL levels usually increase [47]. More-
over, among healthy adults following a low-carbohydrate diet, the LDL increase is
due to increased LDL particle size rather than particle number, which may be
associated with a lower risk of atherosclerosis [56]. Furthermore, LDL and total
cholesterol levels typically normalize within a year of commencing the diet [57],
and return to baseline within 3 months of stopping it [50]. Weight loss is also
common on a ketogenic diet, seen in at least one-fifth of adult with epilepsy [48],
but since many such adults are overweight or obese, this adverse effect is often
desired and beneficial [47]. Other adverse effects, such as kidney stones and
osteopenia or osteoporosis, are rare in adults [47].
Benefits other than seizure control may also occur with a ketogenic diet, includ-
ing improved arousal, alertness, concentration, energy, and mood [3, 47]. More-
over, adults on a ketogenic diet often report increased quality of life scores [58].
Given that many adults with epilepsy suffer from impaired quality of life, these
additional benefits may be significant and should be documented.
4.3.3 Diet cessation
Unlike children, the long-term benefits on seizure control in adults with epilepsy
may not outlast dietary therapy [59]. Further studies are needed to determine if this
is the case for all adults.
It is customary to maintain a ketogenic diet for at least 3 months before passing
judgment on its efficacy in seizure control [3]. The exception to this rule is if the
seizures worsen for longer than 1–2 weeks after commencing the diet, or if a serious
adverse effect occurs—in either case, it may be wise to discontinue the diet sooner.
If the adult experiences a greater than 50% seizure reduction and no serious
adverse effects, their ketogenic diet can be maintained indefinitely [3]. If the adult
starts to perceive their diet as overly restrictive, yet it remains effective at control-
ling seizures, it can be switched over to another type of ketogenic diet.
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Most ketogenic diets in adults are ceased slowly, over weeks or months on an
individual basis [3], although many can be ceased abruptly without negative con-
sequences. The sole exception may be the CKD, which can be ceased gradually by
decreasing the ratio of fat to protein plus carbohydrate weekly or monthly, from 4:1
to 3:1 to 2:1 to 1:1, followed by the reintroduction of regular foods.
An important consideration during diet cessation is the effect on driving restric-
tions. If a ketogenic diet has conferred complete seizure freedom for a long enough
period of time such that the adult has returned to driving, stopping the diet applies
the same driving restrictions as when anti-epileptic drugs are altered or modified [3].
5. Conclusions
Historically, ketogenic diets have been utilized as “end of the line” therapeutic
options in children and adults with epilepsy. However, given recent advances in the
possible mechanisms through which these diets improve seizure control and the
growing evidence base supporting their use in epilepsy, this is changing. Significant
challenges to the more widespread use of ketogenic diets in children and adults with
epilepsy remain, most conspicuously a lack of access to ketogenic services in many
regions of the world. Moreover, the culinary and social restrictions associated with
conventional ketogenic diets are barriers to their use in adults. If these issues can be
addressed, there may come a day when ketogenic diet therapies are utilized more
widely, as first-line options alongside drugs and surgery, in the management of
children and adults with epilepsy.
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